Intellia Therapeutics, Inc.
Overview
Intellia Therapeutics, Inc. is a leading biotechnology company specializing in the development of CRISPR/Cas9 gene-editing technology to create transformative medicines. The company is focused on developing innovative therapies for genetic diseases and cancer, aiming to provide patients with one-time, potentially curative treatments.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Intellia Therapeutics, Inc. in our records. PharmaTek screens the full directory against live FDA enforcement data.
Is this Intellia Therapeutics, Inc.? Get in front of buyers actively sourcing.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.